Business ❯ Healthcare ❯ Clinical Trials

Drug Development

Regulatory Approval Syndax Pharmaceuticals Phase Trials CFTR Modulators EGFR-Mutated NSCLC Jubilant Pharmova Novo Nordisk Products Orexin Drugs Pulmonary Diseases Therapeutic Innovations Oncology Therapeutics Pipeline Management

Summit Therapeutics Shares Rally as Ivonescimab Trials Near Q2 Readout

Investor interest reflects looming data that could shape the drug’s path through FDA review.

Kynam Trims Syndax Stake With $8.18 Million Q4 Sale Disclosed in SEC Filing

Alkermes to Buy Avadel in Up to $2.1 Billion Deal With CVR Tied to Lumryz Expansion